ArticleParasitology2025
Evaluation of the recombinant protein
María Pilar Luzón-García, Laura Navarro, Esther Rodríguez, Manuel Jesús Soriano-Pérez, José Vázquez-Villegas, María Isabel Cabeza-Barrera, Alex Loukas, Nerea Castillo-Fernández, María Jesús Perteguer, Javier Sotillo and 1 more
Abstract readComparative StudyEvaluation Study
In one paragraphArticle in Parasitology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
María Pilar Luzón-GarcíaTropical Medicine Unit, Hospital Universitario Poniente, Ctra. de Almerimar 31, 04700 El Ejido, Spain.
Laura NavarroParasitology Reference and Research Laboratory, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Esther RodríguezParasitology Reference and Research Laboratory, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Manuel Jesús Soriano-PérezTropical Medicine Unit, Hospital Universitario Poniente, Ctra. de Almerimar 31, 04700 El Ejido, Spain.
José Vázquez-VillegasTropical Medicine Unit, Distrito Poniente de Almería, Almería, Spain.
María Isabel Cabeza-BarreraTropical Medicine Unit, Hospital Universitario Poniente, Ctra. de Almerimar 31, 04700 El Ejido, Spain.
Alex LoukasAustralian Institute of Tropical Health and Medicine, James Cook University, Cairns, Australia.
Nerea Castillo-FernándezTropical Medicine Unit, Hospital Universitario Poniente, Ctra. de Almerimar 31, 04700 El Ejido, Spain.
María Jesús PerteguerCIBERINFEC, ISCIII, Instituto de Salud Carlos III, Madrid, Spain.
Funding
Consejería de Salud y Bienestar Social, Junta de Andalucía PI-0001-2019Instituto de Salud Carlos III AESI-PI22CIII/00010Instituto de Salud Carlos III AESI-PI23CIII/00034Red de Investigación Cooperativa en Enfermedades Tropicales RD16/0027/0013
6 · The paper itselfAbstract
Different agencies have emphasized the need to evaluate current serological methods for screening patients with suspected urogenital schistosomiasis. However, there is still a lack of evidence regarding the most appropriate methods for this purpose. Here we assessed the diagnostic efficacy of a newly developed serological technique that utilizes the recombinant protein
Indexed as
Antigens, HelminthHelminth ProteinsSchistosoma haematobiumSchistosomiasis haematobiaSerologic TestsAdolescentAdultAnimalsAntibodies, HelminthEnzyme-Linked Immunosorbent AssayFemaleHumansImmunoglobulin GMaleMiddle AgedRecombinant ProteinsAntibodies, HelminthAntigens, HelminthHelminth ProteinsImmunoglobulin GRecombinant ProteinsdiagnosticsmigrantsSchistosoma haematobiumtravellersurogenital schistosomiasis
Identifiers
PMID39838901
PMCPMC12088922
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390